Dr. Julia Wattacheril and patients join the Global Liver Institute's discussion on the best practices in care management for non-alcoholic fatty liver disease (NAFLD)—now called metabolic dysfunction-associated steatotic liver disease (MASLD)—and strategies to ensure equitable access to screening, diagnosis, and treatment. It's all about letting the patient lead.

Read more here: [ Ссылка ]

свернуть